See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Phase II trial of brostallicin and cisplatin in patients with metastatic triple negative breast cancer
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-ddb0-0316-9953-50a980000000
Resource Type
Properties
-
-
ClinicalTrials.gov url
-
http://www.clinicaltrials.gov/ct2/show/NCT01091454?term=N0937&rank=1
-
-
Intervention
-
Brostacillin/cisplatin
-
-
Additional Topic(s)
-
Combina
-
-
Resource Description
-
Drugs used in chemotherapy, such as brostallicin and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving brostallicin together with cisplatin may kill more tumor cells.
This phase II trial is studying how well giving brostallicin together with cisplatin works in treating patients with metastatic breast cancer.
-
-
Contact
-
Berenberg, Jeffrey
-
-
PI
-
Berenberg, Jeffrey
-
-
Topic
-
breast cancer
-
-
Study Population
-
Men and women 18 years and older with adenocarcinoma of the breast
-
-
Funded by
-
North Central Cancer Treatment Group
-
-
Phase
-
Phase 2 clinical trial
-
-
Performed by
-
Clinical Protocol & Data Management Shared Resource
